Try our mobile app

General information

Country: UNITED STATES

Sector: Medical Devices

Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company"s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.
Website: abbott.com


  • Good financial results growth rate 11.0% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-4.0%)
  • Dividend yield for the last twelve months 1.9%
  • Free cash flow yield 0.7% (LTM)
  • Share price is 39.0% higher than minimum and 10.6% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (26.6x vs
    )
  • Fundamental value created in LTM (estimate)
  • For the last 3 months insiders sold company shares on $0.3 mln (0.000% of cap.)

Key Financials (Download financials)

Ticker: ABT
Share price, USD:  (+4.0%)125.32
year average price 122.33  


year start price 102.03 2024-07-19

min close price 102.03 2024-07-19

max close price 140.22 2025-03-03

current price 125.06 2025-07-18
Common stocks: 1 746 881 140

Dividend Yield:  1.9%
FCF Yield LTM: 0.7%
EV / LTM EBITDA: 26.6x
EV / EBITDA annualized: 26.8x
Last revenue growth (y/y):  +4.0%
Last growth of EBITDA (y/y):  +18.0%
Historical revenue growth:  -1.2%
Historical growth of EBITDA:  -6.7%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 218 919
Net Debt ($m): 6 667
EV (Enterprise Value): 225 586
EBITDA LTM ($m): 8 475
EV / LTM EBITDA: 26.6x
Price to Book: 5.3x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-07-18zacks.com

Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?

2025-07-18seekingalpha.com

Abbott Laboratories: What's Behind The Q2 Earnings Slump?

2025-07-17youtube.com

Didn't see the recovery in China we were expecting, says Abbott Labs CEO on lowering guidance

2025-07-17seekingalpha.com

Abbott Laboratories (ABT) Q2 2025 Earnings Call Transcript

2025-07-17zacks.com

Abbott Stock Falls in Pre-Market Despite Q2 Earnings and Sales Beat

2025-07-17proactiveinvestors.com

Abbott Laboratories shares slide as cautious guidance overshadows Q2 revenue beat

2025-07-17zacks.com

Abbott (ABT) Q2 Earnings and Revenues Top Estimates

2025-07-17reuters.com

Abbott beats quarterly profit estimates on medical devices demand

2025-07-17prnewswire.com

Abbott Reports Second-Quarter 2025 Results

2025-07-15zacks.com

3 Medical Stocks to Watch as Q2 Earnings Approach: ABT, JNJ, NVS
More information for subscribed users:
detailed calculation of
Potential and Created Value,
website traffic data